Janosch Achenbach
Janosch Achenbach
Unknown affiliation
Verified email at
Cited by
Cited by
Emergence of succinate dehydrogenase inhibitor resistance of Pyrenophora teres in Europe
A Rehfus, S Miessner, J Achenbach, D Strobel, R Bryson, G Stammler
Pest Management Science 72 (10), 1977-1988, 2016
Computational tools for polypharmacology and repurposing
J Achenbach, P Tiikkainen, L Franke, E Proschak
Future medicinal chemistry 3 (8), 961-968, 2011
VAMMPIRE: a matched molecular pairs database for structure-based drug design and optimization
J Weber, J Achenbach, D Moser, E Proschak
Journal of medicinal chemistry 56 (12), 5203-5207, 2013
Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering
D Moser, JM Wisniewska, S Hahn, J Achenbach, E Buscató, FM Klingler, ...
ACS Medicinal Chemistry Letters 3 (2), 155-158, 2012
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators
P Heitel, J Achenbach, D Moser, E Proschak, D Merk
Bioorganic & Medicinal Chemistry Letters 27 (5), 1193-1198, 2017
Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity
R Steri, J Achenbach, D Steinhilber, M Schubert-Zsilavecz, E Proschak
Biochemical Pharmacology 83 (12), 1674-1681, 2012
Exploring the chemical space of multitarget ligands using aligned self-organizing maps
J Achenbach, FM Klingler, R Blöcher, D Moser, AK Häfner, CB Rödl, ...
ACS Medicinal Chemistry Letters 4 (12), 1169-1172, 2013
Argyreia nervosa (Burm. f.): receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches
A Paulke, C Kremer, C Wunder, J Achenbach, B Djahanschiri, A Elias, ...
Journal of ethnopharmacology 148 (2), 492-497, 2013
Multi-dimensional target profiling of N, 4-diaryl-1, 3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism
CB Rödl, D Vogt, SBM Kretschmer, K Ihlefeld, S Barzen, A Brüggerhoff, ...
European Journal of Medicinal Chemistry 84, 302-311, 2014
Molecular characterization of EP6—A novel imidazo [1, 2-a] pyridine based direct 5-lipoxygenase inhibitor
JM Wisniewska, CB Rödl, AS Kahnt, E la Buscató, S Ulrich, Y Tanrikulu, ...
Biochemical pharmacology 83 (2), 228-240, 2012
In silico models to predict the perturbation of molecular initiating events related to thyroid hormone homeostasis
M Garcia de Lomana, AG Weber, B Birk, R Landsiedel, J Achenbach, ...
Chemical research in toxicology 34 (2), 396-411, 2020
Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening
D Moser, J Achenbach, FM Klingler, S Hahn, E Proschak
Bioorganic & medicinal chemistry letters 22 (21), 6762-6765, 2012
KnowTox: pipeline and case study for confident prediction of potential toxic effects of compounds in early phases of development
A Morger, M Mathea, JH Achenbach, A Wolf, R Buesen, KJ Schleifer, ...
Journal of Cheminformatics 12 (1), 24, 2020
Synthetic cannabinoids: In silico prediction of the cannabinoid receptor 1 affinity by a quantitative structure-activity relationship model
A Paulke, E Proschak, K Sommer, J Achenbach, C Wunder, SW Toennes
Toxicology letters 245, 1-6, 2016
Complementary screening techniques yielded fragments that inhibit the phosphatase activity of soluble epoxide hydrolase
S Hahn, J Achenbach, E Buscató, FM Klingler, M Schroeder, K Meirer, ...
ChemMedChem 6 (12), 2146-2149, 2011
PENG: a neural gas-based approach for pharmacophore elucidation. Method design, validation, and virtual screening for novel ligands of LTA4H
D Moser, SK Wittmann, J Kramer, R Blöcher, J Achenbach, ...
Journal of Chemical Information and Modeling 55 (2), 284-293, 2015
VAMMPIRE-LORD: a web server for straightforward lead optimization using matched molecular pairs
J Weber, J Achenbach, D Moser, E Proschak
Journal of chemical information and modeling 55 (2), 207-213, 2015
Identification of novel farnesoid X receptor modulators using a combined ligand-and structure-based virtual screening
J Achenbach, M Gabler, R Steri, M Schubert-Zsilavecz, E Proschak
MedChemComm 4 (6), 920-924, 2013
Pyrazolo [1, 5a] pyrimidines as a new class of FUSE binding protein 1 (FUBP1) inhibitors
S Hauck, K Hiesinger, SK Hosseini, J Achenbach, RM Biondi, E Proschak, ...
Bioorganic & Medicinal Chemistry 24 (22), 5717-5729, 2016
Computer-aided selective optimization of side activities of talinolol
K Hiesinger, JS Kramer, J Achenbach, D Moser, J Weber, SK Wittmann, ...
ACS Medicinal Chemistry Letters 10 (6), 899-903, 2019
The system can't perform the operation now. Try again later.
Articles 1–20